SAIMSARA Journal

Machine-Readable Science • ISSN 3054-3991

Jogging and Cardiovascular Health Benefits and Risks Across Populations: Scoping Review with ☸️SAIMSARA

Cardiac & Vascular Health icon

Cardiac & Vascular Health

Issue 1, Volume 1, 2026

DOI: 10.62487/saimsara228fb6f6

Editorial note
• Last update: 2026-06-12 21:27:52
What is this paper about
Jogging delivers broad cardiovascular benefits, from improved fitness, blood pressure, and lipid profiles to lower mortality, but it also carries a small acute risk in susceptible individuals. The full read reveals the safest exercise dose, the populations most likely to benefit, and the warning signs that should shape personalized cardiovascular screening and prescription.
Human-verified editorial review Verified by World ID proof-of-human. This editorial layer was submitted from a SAIMSARA account verified as a unique human.


Generated with SAIMSARA v5.0

Video summary generated from this ☸️SAIMSARA evidence map. Full reference-linked paper and evidence JSON are available after purchase.



Abstract: To systematically map the breadth and depth of original research examining the associations, mechanisms, and clinical implications of jogging for cardiovascular health, disease, and risk, synthesizing findings across the translational spectrum from molecular biomarkers to population-level mortality outcomes. The review uses 59 references and builds its evidence map from 86 original studies with 786886 total participants/sample observations (topic-deduplicated ΣN). This scoping review indicates that habitual, moderate-volume jogging is broadly associated with cardiovascular benefit, alongside a small but reproducible acute hazard in susceptible individuals. The most recurrent signals link regular jogging to lower all-cause mortality and improved cardiorespiratory and metabolic profiles, including jogging being uniquely associated with both higher HDL cholesterol and lower triglycerides across large cohorts. At the same time, jogging was identified as a triggering activity in 14–17% of sports-related sudden cardiac deaths, predominantly reflecting underlying ischemic heart disease. These patterns support a role for individualized exercise prescription paired with pre-participation cardiovascular screening, particularly in middle-aged adults with risk factors. Because evidence rests largely on heterogeneous, modestly sized studies, future prospective work linking device-measured jogging exposure to personalized risk stratification is needed to clarify optimal dosing and identify those at elevated acute risk.
.

Keywords: jogging; cardiovascular disease; all-cause mortality; cardiorespiratory fitness; sudden cardiac death; inflammatory markers; blood pressure; heart rate; lipid profile; exercise intensity

Review Stats

Get access to the full paper

Unlock the full evidence map

Full paper access includes the complete human-readable review, figures, reference index, PDF export, and machine-readable Evidence JSON download.
Evidence JSON can also be purchased separately if you only need the LLM-ready object for agent, AI, or RAG workflows.
Institutional or library access? Sign in with your institution email to open all available SAIMSARA papers under your institution access arrangement.
Need a SAIMSARA review on your own topic? ☸️Request.

Reference Index (59)

Unlock the full paper to view the complete Reference Index.